-
Thematic Analysis
NewRegulated mHealth Apps – Thematic Intelligence
Reasons to buy the ‘Regulated mHealth Apps’ thematic intelligence report: Gain insights on the key trends impacting the regulated mobile health apps theme, classified by technology, regulatory, and macroeconomic trends over the next 12 to 24 months. Understand how big the mHealth theme is, how fast it will grow, its timeline, and how the theme will develop. Analyze the core components of the mobile health value chain which includes mHealth devices, mHealth apps, mHealth app use, and experience. Find out...
-
Thematic Analysis
DTx in Medical – Thematic Intelligence
DTX in Medical Thematic Report Overview Digital therapeutics (DTx) are software-based interventions that deliver evidence-based therapeutic interventions to patients. The interventions are driven by high-quality software programs to prevent, manage, or treat a medical condition. The majority of DTx are designed to treat chronic, respiratory, and mental health or neurological conditions. The use of DTx generally requires a prescription, as the interventions must be cleared or certified by regulatory bodies to support their claims. The DTx in medical thematic intelligence...
-
Thematic Analysis
Digital Therapeutics – Thematic Intelligence
Explore actionable trends and insights with the following data sets in the ‘Digital Therapeutics’ report: Market analysis of approved and reimbursed digital therapeutic products by region. Case studies with in-depth insight into some of the most recent and most influential developments in the digital therapeutics theme. Product profiles of disruptive digital therapeutic products across key therapeutic areas. A focused chapter on the key healthcare, technology, macroeconomic, and regulatory trends impacting digital therapeutics, and a review of how these trends will...
-
Product Insights
NewAkili Interactive Labs Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Akili Interactive Labs Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Akili Interactive Labs Inc (Akili Interactive) is a prescription digital medicine company that develops digital medical treatments with direct therapeutic activity. Akili’s prescription digital medicine is delivered through a creative and immersive action video game experience. Treatments leverage art, music, storytelling and reward cycles to keep patients engaged and immersed for the delivery of therapeutic activity in a...
-
Track & Monitor
Cloud in Healthcare: Clinical Data Management Systems
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Track & Monitor
Cybersecurity in Healthcare: Clinical Data Management Systems
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Track & Monitor
Wearable Tech in Healthcare: Sleep Assistance Devices
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Track & Monitor
Innovation in Healthcare: Sleep Pods
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Sector Analysis
Digital Biomarkers Market Size, Share and Trends Analysis by Region, Product Type (Wearable Application, Mobile Application, Portables), End-user (Healthcare Companies and Services, Others), and Segment Forecast, 2022-2027
The digital biomarkers market size was valued at US$2.32 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 25.7% during 2022-2027. The key to the digital biomarkers market growth has been the aging population and rise in chronic diseases, increasing investments and funding to develop digital biomarkers, and increasing role of digital biomarkers in clinical trials. Additionally, key strategic partnerships and mergers and acquisitions are expected to accelerate market growth. Over the forecast...
-
Report Bundle
58% offTech in Pharma – Report Bundle (7 Reports)
Tech in Pharma Bundle Report Overview Although the pharmaceutical industry had been slow to adopt technological innovations, the onset of COVID-19 has dramatically altered the situation. The latest technologies, Augmented Reality (AR), Big Data, and Artificial Intelligence (AI), among others, will assist pharmaceutical companies in speeding up the research and development process, creating personalized products, and conducting testing in novel ways. Finally, these technologies will improve healthcare effectiveness and efficiency thereby transforming the patient and provider experience. Explore actionable market...